- Home
- CYTK vs AMTM Comparison
CYTK vs AMTM Comparison
Compare CYTK & AMTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTK
- AMTM
- Stock Information
- Founded
- CYTK 1997
- AMTM 2020
- Country
- CYTK United States
- AMTM United States
- Employees
- CYTK N/A
- AMTM N/A
- Industry
- CYTK Biotechnology: Pharmaceutical Preparations
- AMTM
- Sector
- CYTK Health Care
- AMTM
- Exchange
- CYTK Nasdaq
- AMTM NYSE
- Market Cap
- CYTK 5.6B
- AMTM 5.6B
- IPO Year
- CYTK 2004
- AMTM N/A
- Fundamental
- Price
- CYTK $34.36
- AMTM $24.29
- Analyst Decision
- CYTK Buy
- AMTM Buy
- Analyst Count
- CYTK 14
- AMTM 6
- Target Price
- CYTK $70.92
- AMTM $25.50
- AVG Volume (30 Days)
- CYTK 1.4M
- AMTM 2.3M
- Earning Date
- CYTK 08-07-2025
- AMTM 08-05-2025
- Dividend Yield
- CYTK N/A
- AMTM N/A
- EPS Growth
- CYTK N/A
- AMTM N/A
- EPS
- CYTK N/A
- AMTM 0.10
- Revenue
- CYTK $19,218,000.00
- AMTM $11,261,000,000.00
- Revenue This Year
- CYTK $34.81
- AMTM $70.67
- Revenue Next Year
- CYTK $643.79
- AMTM $2.35
- P/E Ratio
- CYTK N/A
- AMTM $254.39
- Revenue Growth
- CYTK 412.21
- AMTM 38.56
- 52 Week Low
- CYTK $29.31
- AMTM $16.01
- 52 Week High
- CYTK $61.38
- AMTM $34.50
- Technical
- Relative Strength Index (RSI)
- CYTK 56.37
- AMTM N/A
- Support Level
- CYTK $32.66
- AMTM N/A
- Resistance Level
- CYTK $34.34
- AMTM N/A
- Average True Range (ATR)
- CYTK 1.33
- AMTM 0.00
- MACD
- CYTK 0.21
- AMTM 0.00
- Stochastic Oscillator
- CYTK 76.45
- AMTM 0.00
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
About AMTM AMENTUM HOLDINGS INC
Amentum Holdings Inc is engaged in engineering and technology solutions. The United States and its allies trust it to address their technical and complex scientific, security, and sustainability challenges.